Results 81 to 90 of about 20,063 (118)

[Clinical analysis of 7 cases of childhood acute lymphoblastic leukemia with <i>PDGFRB</i> rearrangement]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Tao YQ, Cui DD, Jia XP, Lian AN, Qi WJ, Zhu P, Wang CM, Sheng GY.   +7 more
europepmc   +1 more source

[Recent advances in individualized treatment for pediatric high-risk B-cell acute lymphoblastic leukemia]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Li YQ, Wang YJ, Li ZZ, Ni JX.
europepmc   +1 more source

[Clinical analysis of nutritional components in children with acute leukemia]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Shi LX, Zhao MZ, Wang FF, Xing YQ, Ji HY, Zhao P.   +5 more
europepmc   +1 more source

[How I treat pediatric chronic myeloid leukemia]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
An WB, Yang WY.
europepmc   +1 more source

[Guideline for the diagnosis and treatment of chronic myeloid leukemia in China (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Chinese Society of Hematology, Chinese Medical Association.   +1 more
europepmc   +1 more source

[Acute megakaryoblastic leukemia with CBFA2T3::GLIS2 fusion gene: 3 cases report and literature review]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Lin S, Guo Y, Zhang L, Chen YM, Xiao JG, Cai XJ, Yang WY, Chen XJ.   +7 more
europepmc   +1 more source

[Prognostic analysis of NUP98 rearrangement in patients with pediatric acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wang HF, Hu GH, Bai L, Suo P, Zhang F, Zuo YX, Liu KY, Xu LP, Wang Y, Sun YQ, He XX, Zhang XH, Huang XJ, Cheng YF.   +13 more
europepmc   +1 more source

[Clinical characteristics and prognosis of acute erythroleukemia in children]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Zhu P, Qi WJ, Tao YQ, Cui DD, Sheng GY, Wang CM.   +5 more
europepmc   +1 more source

[Clinical characteristics of DUX4-IGH fusion B-cell acute lymphoblastic leukemia in children]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Luo YX, Jiang H, Wang JY, Hao WG, Zhang WN.   +4 more
europepmc   +1 more source

[Analysis of the efficacy of half-dose venetoclax combined with reduced-dose HA regimen in the induction therapy of acute myeloid leukemia]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Yan ZS, Suo XH, Bai GC, Zhang B, He JS, Li JS, Wei SN, Li QL, Liu KQ, Mi YC.   +9 more
europepmc   +1 more source